Fingerprint
Dive into the research topics of 'Secukinumab in plaque psoriasis - Results of two phase 3 trials'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Secukinumab in plaque psoriasis - Results of two phase 3 trials
Richard G. Langley*, Boni E. Elewski, Mark Lebwohl, Kristian Reich, Christopher E.M. Griffiths, Kim Papp, Lluís Puig, Hidemi Nakagawa, Lynda Spelman, Bárour Sigurgeirsson, Enrique Rivas, Tsen Fang Tsai, Norman Wasel, Stephen Tyring, Thomas Salko, Isabelle Hampele, Marianne Notter, Alexander Karpov, Silvia Helou, Charis Papavassilis
*Corresponding author for this work
- Dalhousie University
- University of Alabama
- Mount Sinai Hospital
- Georg August University Göttingen
- University of Manchester
- Clinical Research
- Probity Medical Research
- Hospital de la Santa Creu i Sant Pau
- Jikei University School of Medicine
- Veracity Clinical Research
- University of Iceland
- Dermos
- National Taiwan University Hospital
- Stratica Medical and Probity Medical Research
- Baylor College of Medicine
- Novartis Pharma AG
1791
Citations
(Scopus)